|    Join     |    Donate    |   Store    |   About NAMS
Facebook TwitterYouTubeLinkedinRSS

CME Information

650x65_112220_AMBanner

Claim Your 2021 Annual Meeting Hours
(For the Live Event in Washington, DC Only)

Online submissions accepted through 11/2/2021. Certificates will be mailed by early-December.

                      
This link is for physicians and other learners who do not need to report pharmacotherapeutic hours.

CME Certificate Without Pharmacotherapeutic Hours
  This link is for nurses and other learners who need to report pharmacotherapeutic hours.
           
Certificate of Participation With Pharmacotherapeutic Hours




Outlined below, the meeting offers opportunities to earn 29.25 AMA PRA Category 1 Credit(s) or certificates of participation. Other healthcare providers who participate in the live activities will receive a certificate of participation. For nurses and other learners who need to report contact hours of pharmacotherapeutic education, NAMS has determined these live activities include a maximum of 12.75 hours of pharmacotherapeutic education.

ACCME


Menopause 101 Course

Menopause 101: The Best of Clinical Practice

The North American Menopause Society (NAMS) designates this live activity for a maximum of 3.75 AMA PRA Category 1 Credit(s). Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Other healthcare providers who participate in this activity will receive a certificate of participation. A maximum of 2.0 pharmacotherapeutic hours are also available.

Learning Objectives

By participating in this activity, attendees should be able to

  • Understand the pathophysiology of menopause
  • Assess the treatment options for vasomotor symptoms, including hormone therapy and alternatives
  • Become familiar with diagnosing and treating genitourinary syndrome of menopause, osteoporosis, and sexual dysfunction
  • Define what’s normal and what’s not in mood and cognition

Pre-Meeting Symposium

Cardiometabolic Health in Midlife Women

The North American Menopause Society (NAMS) designates this live activity for a maximum of 4.5 AMA PRA Category 1 Credit(s). Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Other healthcare providers who participate in this activity will receive a certificate of participation. A maximum of 2.0 pharmacotherapeutic hours are also available.

Learning Objectives

By participating in this activity, attendees should be able to

  • Understand cardiovascular disease symptoms and novel risk factors in women
  • Evaluate recommendations for beginning statins and specific risk factors in women
  • Become familiar with the medical management of obesity
  • Appreciate the disparities in care in women’s heart health
  • Recognize the cardiovascular consequences in women with diabetes
  • Explore food as medicine for cardiometabolic health



Annual Meeting

NAMS 2021: The State of Midlife Women’s Health Today

The North American Menopause Society (NAMS) designates this live activity for a maximum of 21.0 AMA PRA Category 1 Credit(s). Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Other healthcare providers who participate in this activity will receive a certificate of participation. A maximum of 8.75 pharmacotherapeutic hours are also available.

Learning Objectives

By participating in this activity, attendees should be able to

  • Recognize issues in clinical practice for women at all stages of the menopause spectrum—perimenopause, menopause, and postmenopause
  • Understand the science of how the brain steers you through menopause
  • Discuss the intersection of research health policy and clinical care
  • Become familiar with breast cancer prevention, screening, and survivorship care
  • Manage menopause in a pandemic and recognize the collateral damage of COVID-19
  • Evaluate bone health and identify how to prevent the first fracture
  • Explore the promises and challenges of gene editing in the age of CRISPR
  • Establish what is abnormal uterine bleeding in perimenopausal and postmenopausal women
  • Analyze what’s new in cervical cancer screening and sexually transmitted infections
  • Interpret the issues surrounding hair loss and voice changes
  • Define female sexual function and when and how to use androgens
  • Appreciate the art of end-of-life care
  • Assess hormonal migraines, migraines at menopause, and treatment options
  • Review the risks and benefits of starting hormone therapy at menopause




Copyright© 2021 |  Home  |  Privacy Policy  |   Site Map |

 

30050 Chagrin Blvd, Suite 120W - Pepper Pike, OH 44124, USA
Telephone: 440/442-7550 - Fax: 440/442-2660  - Email: info@menopause.org
Email a Friend
close
Please enter a valid email address.
255 character limit
Your friend will receive an e-mail invitation to view this page, but we will not store or share this e-mail address with outside parties.

To submit the email please enter the sum of 9 + 4.